Danielle Brazel

Will the clinical development of 4th-generation “double mutant active” ALK TKIs (TPX-0131 and NVL-655) change the future treatment paradigm of ALK+ NSCLC?

Sai‐Hong Ignatius Ou, Misako Nagasaka, Danielle Brazel et al. · Translational Oncology · 2021 · 43 citations · Full text

Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation

Danielle Brazel, Shannon Zhang, Misako Nagasaka · Lung Cancer Targets and Therapy · 2022 · 21 citations · Full text

Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset

Misako Nagasaka, Danielle Brazel, Yasmine Baca et al. · Translational Oncology · 2023 · 18 citations · Full text

Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma

Danielle Brazel, Priyanka Kumar, Hung Q. Doan et al. · JAMA Network Open · 2023 · 15 citations · Full text

Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC

Danielle Brazel, Misako Nagasaka · Targeted Oncology · 2024 · 15 citations · Full text